Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 4, 2007, Pages 367-370

  Arora, Rajiv ^a   Newton, Thomas C ^a   Nelson, Michael R ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LAMOTRIGINE;

ARTICLE; B LYMPHOCYTE; BACTERIOPHAGE; BLEEDING; CASE REPORT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CONTINUOUS INFUSION; DEVICE REMOVAL; DRUG TOLERABILITY; HEART RIGHT ATRIUM; HUMAN; HUMORAL IMMUNITY; INDWELLING CATHETER; INFECTION COMPLICATION; INJECTION SITE DISCOMFORT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN BRUISING; TREATMENT RESPONSE; VASCULAR ACCESS; VON WILLEBRAND DISEASE;

EID: 35349013496     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60555-8     Document Type: Article

References (14)

1. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722-728.
2. Berger M. Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol. 2004;112:1-7.
3. Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94:S1-S63.
4. Kelkar PS, Ten RM. Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand's disease in a family cluster. J Allergy Clin Immunol. 2001;107:742.
5. Moffat EH, Bloom AL, Jones J, Matthews N, Newcombe RG. A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol. 1985;61:157-167.
6. Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child. 1998;79:48-51.
7. Gardulf A, Hammerstrom L, Smith CIE. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet. 1991;338:162-166.
8. Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorklander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20:94-100.
9. Ugazio AG, Duse M, Re R, Mangli G, Burgio GR. Subcutaneous infusion of gammaglobulins in management of agammaglobulinemia. Lancet. 1982;1:226.
10. Gardulf A, Bjorvell H, Gustafson R, Hammarstrom L, Smith CI. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol. 1993;92:200-204.
11. Gardulf A, Nicolay U, Asensio O, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-insusions at home. J Allergy Clin Immunol. 2004;114:936-942.
12. Abrahamsen TG, Sanderson H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Paediatrics. 1996;98:1127-1131.
13. Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet. 1995;345:365-369.
14. Rick ME, Walsh CE, Key NS. Congenital bleeding disorders. Hematology (Am Soc Hematol Educ Prog). 2003;1:559-574.